Françoise Barré‐Sinoussi

Author

Also Known As

Barre-Sinoussi, Francoise, F BARRE-SINOUSSI, F Barre-Sinoussi, F Barré-Sinoussi, F Barré-Sinoussi, F Barré‐Sinoussi, F. BARRE-SINOUSSI, F. Barre-Sinoussi, F. Barré-Sinoussi, F. Barré-Sinoussi

291

Publications

25K

Citations

H-Index

122

Concepts

All Affiliations

Institut Pasteur Inserm Université Paris Cité Sorbonne Université Commissariat à l'Énergie Atomique et aux Énergies Alternatives

About

Françoise Barré‐Sinoussi is an author at Institut Pasteur specializing in medicine, hiv, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	48	81	16K
2	Natural Sciences	7	7	1.3K
3	Education	1	1	448
4	Engineering	1	1	15
5	Law	1	1	46

Françoise Barré‐Sinoussi

167

Publications

21.9K

Citations

H-Index

Page 1

	Year	Citations
Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS) Françoise Barré‐Sinoussi, Jean‐Claude Chermann, FA Rey, Science Primary ImmunodeficiencyHtlv P24Diagnostic VirologyViral PersistenceAutoimmune Disease	1983	6.9K
Selective Tropism of Lymphadenopathy Associated Virus (LAV) for Helper-Inducer T Lymphocytes David Klatzmann, Françoise Barré‐Sinoussi, Marie Thèrése Nugeyre, Science Primary ImmunodeficiencyImmune DeficiencyLymphadenopathy Associated VirusSelective TropismElectron Microscopy	1984	965
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection <i>ex vivo</i> and peculiar cytotoxic T lymphocyte activation phenotype Asier Sáez‐Cirión, Christine Lacabaratz, Olivier Lambotte, Proceedings of the National Academy of Sciences Adaptive Immune SystemImmunologyImmunodominanceCd4 T Cell ResponsesT Cells	2007	616
Identification of a new human immunodeficiency virus type 1 distinct from group M and group O François Simon, Philippe Mauclère, Pierre Roques, Nature Medicine Primary ImmunodeficiencyGroup OGroup MHuman RetrovirusImmunology	1998	562
Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response Béatrice Jacquelin, Véronique Mayau, Brice Targat, Journal of Clinical Investigation Nonpathogenic Siv InfectionImmunologyViral PathogenesisPathologyAfrican Green Monkeys	2009	472
Animal Models are Essential to Biological Research: Issues and Perspectives Françoise Barré‐Sinoussi, Xavier Montagutelli Future Science OA Animal WelfareEducationSocieties.the RemarkableResearch EthicsLaboratory Animal Study	2015	448
Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus. Marc Girard, M. P. Kieny, Abraham Pinter, Proceedings of the National Academy of Sciences Primary ImmunodeficiencyVaccinationChimpanzees Confers ProtectionEpitope V3Sequential Injections	1991	353
Adaptation of Lymphadenopathy Associated Virus (LAV) to Replication in EBV-Transformed B Lymphoblastoid Cell Lines Luc Montagnier, J Gruest, S. Chamaret, Science	1984	351
Cis elements and Trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1 Jean‐Luc Darlix, Caroline Gabus, Marie-Thérèse Nugeyre, Journal of Molecular Biology Viral ReplicationSystems BiologyNatural SciencesHuman RetrovirusRna Structure Prediction	1990	325
INACTIVATION OF LYMPHADENOPATHY-ASSOCIATED VIRUS BY HEAT, GAMMA RAYS, AND ULTRAVIOLET LIGHT Bruno Spire, Françoise Barré‐Sinoussi, Dominique Dormont, The Lancet Diagnostic VirologyMolecular VirologyViral PersistenceAnd Ultraviolet LightPathogenesis	1985	301

Page 1